Evidence map›Paper›PMID 32855514›Full record

ReviewPediatric research2020

Opportunities for the federal government to advance necrotizing enterocolitis research.

Samir K Gadepalli, Jennifer Canvasser, Misty Good, Tonse N K Raju

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samir K GadepalliDivision of Pediatric Surgery, Department of Surgery, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA. samirg@med.umich.edu.
Jennifer CanvasserNecrotizing Enterocolitis (NEC) Society, Davis, CA, USA.
Misty GoodDivision of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Tonse N K RajuDepartment of Pediatrics, F. Edward Hébert School of Medicine, Uniformed Services University, Bethesda, MD, USA.

Funding

Modulation of the Intestinal Immune Response in Necrotizing EnterocolitisR01DK118568 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L · 2018 to 2022
$1.8M
Breaking Down the Barriers of NEC Prevention and TreatmentR13HD098853 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GADEPALLI, SAMIR KUMAR · 2019 to 2019
$10k
NICHD NIH HHS R13 HD098853NIDDK NIH HHS R01 DK118568
6 · The paper itself

Abstract

backgroundNecrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality in the neonatal ICU with minimal progress in the research.

methodsFederal webpages were queried to look for funding opportunity announcements (FOAs) and to develop lists of funded projects on NEC to identify gaps in NEC-related research topics.

resultsOver the past 30 years, the National Institutes of Health (NIH) issued two FOAs to stimulate research on NEC with $4.1 million set aside for the first year of respective funding. We identified 23 recently funded studies of which 18 were research projects, 4 training grants, and 1 conference grant support. Only one grant focused on parent and family engagement in the NICU.

conclusionThere are significant research gaps that can be addressed with adequate funding from the federal government on the prevention and treatment of NEC.

Indexed as

Financing, GovernmentClinical Trials as TopicEnterocolitis, NecrotizingFamily HealthFederal GovernmentHumansInfantInfant, NewbornInfant, Newborn, DiseasesIntensive Care, NeonatalIntensive Care Units, NeonatalNational Institutes of Health (U.S.)NeonatologyResearch DesignResearch Support as TopicTreatment Outcome

Identifiers

PMID32855514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.